The symptomatic presentation of AD is characterised by progressive memory loss and decline in cognitive function, accompanied by neurotoxic accumulation of amyloid-β plaques and intracellular hyperphosphorylated tau (p-tau) [3, 4]. Here, MAPT is linked to Alzheimer disease.